A clinical trial to look at how safe forimtamig-based treatment combinations are and how well they work in people with relapsed or refractory multiple myeloma
A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma
-
Cancer -
Multiple Myeloma -
Relapsed or Refractory Multiple Myeloma
For the latest version of this information please go to www.forpatients.roche.com